Skip to content
cardio.webdr
ToolsSpecialtiesEchoHeart sounds
ToolsSpecialtiesEchoHeart soundsFavoritesPrivate notes
cardio.webdr

Clinical clarity, in seconds. Built for focused decisions—not data collection.

Patient inputs stay on this device.
ExploreAll toolsSpecialtiesEchocardiographyHeart sounds
Your workspaceFavoritesPrivate notesCalculation historyOffline access
PlatformAboutFAQDevelopersFeedbackContact
© 2026 CardioWebdr Clinical support, not a substitute for judgment.PrivacyTermsStorageSupportReport an issue
All tools/Cardiomyopathy Scores
Interactive worksheet4 clinical inputsPatient data not stored

CS-CHD Score Calculator

CS-CHD Score: Explanation and Clinical Context The CS-CHD Score is a prognostic model developed to estimate the risk of adverse cardiovascular events in patients with cardiac sarcoidosis. It incorporates clinical parameters such as left ventricular ejection fraction (LVEF), B-type natriuretic peptide (BNP) levels, history of ventricular arrhythmias, and need for ablation therapy. Higher scores indicate increased risk

Interactive worksheet

Clinical inputs

0/4 filled
Inputs stay on this device
Active structured worksheetActive local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.
Clinical contextWhy this tool matters and how to interpret it

Understand the result,
not just the number.

CS-CHD Score: Explanation and Clinical Context The CS-CHD Score is a prognostic model developed to estimate the risk of adverse cardiovascular events in patients with cardiac sarcoidosis. It incorporates clinical parameters such as left ventricular ejection fraction (LVEF), B-type natriuretic peptide (BNP) levels, history of ventricular arrhythmias, and need for ablation therapy. Higher scores indicate increased risk of events like fatal ventricular arrhythmias, heart failure hospitalizations, and all-cause mortality.

This tool assists clinicians in stratifying patients and guiding management decisions.

Evidence & references1 primary source mapped
  1. Source 1

    Nabeta T, et al. Risk Stratification of Patients With Cardiac Sarcoidosis. Eur Heart J. 2022;43(36):3450-3459. doi:10.1093/eurheartj/ehac323

Clinical discussionModerated, tool-specific conversation

Loading discussion…

Moderated before publishingNever include patient identifiers.

Workspace mode

Structured worksheet

Active local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.

On this pageWorksheet Clinical context References Discussion

Privacy by default

Inputs, results, favorites, and notes remain in your browser unless you explicitly export them.

Privacy details
Report formula or content issue
Continue exploring

Related clinical tools

More in this specialty
Interactive worksheet

Amyloidosis Cardiac Stage (Mayo 2012) Calculator

Cardiomyopathy Scores
Interactive worksheet

Maron Model (HCM SCD Prediction) Calculator

Cardiomyopathy Scores
Interactive worksheet

T1/T2 Mapping Ratio in Myocarditis Calculator

Cardiomyopathy Scores
Interactive worksheet

PYP Quantitative Uptake Index (QUI) Calculator

Cardiomyopathy Scores
Clinical structure and calculation context point directly to Source 1; additional primary references remain listed for auditability.